Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity

These findings indicate that the sensitivity prediction model constructed through the integration of DEG and machine learning analyses can forecast drug sensitivity, thereby contributing to the advancement of effective and personalized precision medicine in classical chemotherapies.

Authors

Institutions

Publication Details

Journal
Cancer Medicine
Published
2025-11-01
DOI
https://doi.org/10.1002/cam4.71373
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity

Honami Yonezawa, Naoyuki Nishiya, Kei Oya, Masao Ôta et al.
Cancer Medicine
Computational Drug Discovery Methods
article

Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity

Honami Yonezawa, Naoyuki Nishiya, Kei Oya, Masao Ôta, Yuto Sugawara, Tomoko Sakyo, Haruki Ujiie
article en

Abstract

These findings indicate that the sensitivity prediction model constructed through the integration of DEG and machine learning analyses can forecast drug sensitivity, thereby contributing to the advancement of effective and personalized precision medicine in classical chemotherapies.

Cancer MedicineVol. 14(22)
Iwate Medical University (JP)
Promotion and Mutual Aid Corporation for Private Schools of Japan
Openalex Percentile: Top 64%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.